The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

With new data from several studies this year, researchers are chipping away at the question of when to revascularize and how.

FastWave Medical's technology delivers energy pulses to break up plaque in arteries caused by coronary artery disease and ...

Researchers have identified that vericiguat, a new drug for heart failure, is safe in patients with coronary artery disease.

A new study published in the Journal of the American College of Cardiology illuminate the critical relationship between ...

THE TCW trial has demonstrated that fractional flow reserve (FFR)-guided percutaneous PCI plus TAVI is superior to SAVR plus ...

That’s where temperature regulation comes into play. When the body gets cold, brown fat is activated. It begins to generate ...

Gary Small, MBChB, PhD “The high prevalence of asymptomatic coronary artery disease (83%) was surprising, as was the prevalence of extensive CAC (30%),” principal investigator Gary Small ...

Coronary artery disease (CAD) is increasingly observed in patients with liver cirrhosis. However, data on the incidence and prevalence of CAD in cirrhotic patients are heterogeneous, and the ...